SE436751B - Forfarande enligt krav 1 i patentet 7613920-3 (publ.nr 423903) for framstellning av 17alfa-acyloxi-9alfa, 21-dihalogen-11beta-hydroxi-6alfa-fluor-16beta-metyl-pregna-1,4-dien-3,20-dion-foreningar - Google Patents

Forfarande enligt krav 1 i patentet 7613920-3 (publ.nr 423903) for framstellning av 17alfa-acyloxi-9alfa, 21-dihalogen-11beta-hydroxi-6alfa-fluor-16beta-metyl-pregna-1,4-dien-3,20-dion-foreningar

Info

Publication number
SE436751B
SE436751B SE7706673A SE7706673A SE436751B SE 436751 B SE436751 B SE 436751B SE 7706673 A SE7706673 A SE 7706673A SE 7706673 A SE7706673 A SE 7706673A SE 436751 B SE436751 B SE 436751B
Authority
SE
Sweden
Prior art keywords
acyloxi
9alfa
6alfa
17alfa
16beta
Prior art date
Application number
SE7706673A
Other languages
English (en)
Swedish (sv)
Other versions
SE7706673L (sv
Inventor
J Kalvoda
G Anner
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE7706673L publication Critical patent/SE7706673L/
Publication of SE436751B publication Critical patent/SE436751B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7706673A 1976-09-29 1977-06-08 Forfarande enligt krav 1 i patentet 7613920-3 (publ.nr 423903) for framstellning av 17alfa-acyloxi-9alfa, 21-dihalogen-11beta-hydroxi-6alfa-fluor-16beta-metyl-pregna-1,4-dien-3,20-dion-foreningar SE436751B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU75903A LU75903A1 (en)van) 1976-09-29 1976-09-29

Publications (2)

Publication Number Publication Date
SE7706673L SE7706673L (sv) 1978-03-30
SE436751B true SE436751B (sv) 1985-01-21

Family

ID=19728370

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7706673A SE436751B (sv) 1976-09-29 1977-06-08 Forfarande enligt krav 1 i patentet 7613920-3 (publ.nr 423903) for framstellning av 17alfa-acyloxi-9alfa, 21-dihalogen-11beta-hydroxi-6alfa-fluor-16beta-metyl-pregna-1,4-dien-3,20-dion-foreningar

Country Status (24)

Country Link
JP (1) JPS5356652A (en)van)
AT (3) AT363197B (en)van)
AU (1) AU514200B2 (en)van)
BE (1) BE859120A (en)van)
CA (1) CA1101410A (en)van)
CH (9) CH624967A5 (en)van)
CY (1) CY1178A (en)van)
DD (1) DD133150A5 (en)van)
DE (1) DE2743069C2 (en)van)
DK (1) DK146017C (en)van)
ES (1) ES462763A1 (en)van)
FR (1) FR2366311A1 (en)van)
GB (1) GB1563638A (en)van)
HK (1) HK16683A (en)van)
HU (1) HU175218B (en)van)
IE (1) IE46047B1 (en)van)
IL (1) IL53012A (en)van)
KE (1) KE3258A (en)van)
LU (1) LU75903A1 (en)van)
MY (1) MY8400092A (en)van)
NL (1) NL7710089A (en)van)
SE (1) SE436751B (en)van)
SG (1) SG3383G (en)van)
ZA (1) ZA775800B (en)van)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
WO1991014700A2 (en) * 1990-03-27 1991-10-03 Schering Corporation PROCESS FOR 9α-HYDROXY STEROID DEHYDRATION
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
JP2005530679A (ja) 2001-11-29 2005-10-13 ターロ ファーマシューティカルズ ユーエスエイ インコーポレイテッド ６α−フルオロコルチコステロイドの調製方法
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
CA2988577A1 (en) 2015-06-18 2016-12-22 Valeant Pharmaceuticals North America Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US3644340A (en) * 1970-03-19 1972-02-22 Syntex Corp Preparation of 21-chloro steroids
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
LU75903A1 (en)van) 1978-05-16
AT363202B (de) 1981-07-27
HK16683A (en) 1983-05-27
FR2366311B1 (en)van) 1982-12-03
IL53012A0 (en) 1977-11-30
AU2914877A (en) 1979-04-05
CH624967A5 (en) 1981-08-31
IE46047L (en) 1978-03-29
DE2743069A1 (de) 1978-03-30
DK256977A (da) 1978-03-30
JPS6214557B2 (en)van) 1987-04-02
CH625808A5 (en) 1981-10-15
MY8400092A (en) 1984-12-31
AU514200B2 (en) 1981-01-29
ATA691077A (de) 1980-12-15
ATA151379A (de) 1980-12-15
HU175218B (hu) 1980-06-28
FR2366311A1 (fr) 1978-04-28
CH632521A5 (en) 1982-10-15
JPS5356652A (en) 1978-05-23
NL7710089A (nl) 1978-03-31
DD133150A5 (de) 1978-12-13
AT363197B (de) 1981-07-10
KE3258A (en) 1983-03-04
IE46047B1 (en) 1983-02-09
CY1178A (en) 1983-06-10
CH632279A5 (en) 1982-09-30
GB1563638A (en) 1980-03-26
CH625810A5 (en) 1981-10-15
CH625809A5 (en) 1981-10-15
CA1101410A (en) 1981-05-19
CH631998A5 (en) 1982-09-15
DE2743069C2 (de) 1987-03-05
ATA151279A (de) 1980-12-15
AT363203B (de) 1981-07-27
BE859120A (fr) 1978-03-28
SE7706673L (sv) 1978-03-30
SG3383G (en) 1983-09-09
DK146017C (da) 1983-10-24
CH632000A5 (en) 1982-09-15
IL53012A (en) 1982-05-31
ES462763A1 (es) 1978-05-16
CH631999A5 (en) 1982-09-15
DK146017B (da) 1983-05-24
ZA775800B (en) 1978-08-30

Similar Documents

Publication Publication Date Title
SE431653B (sv) Forfarande for framstellning av 2,3-dihydro-imidazo/2,1-b/tiazolderivat
RO71931A (ro) Procedeu pentru prepararea unor feniletilamino-derivati ai 3,4-dihidro-2h-izochinolin-1-onei sau ai 1,2,3,4-tetrahidro-5h-benzazepin-1-onei
RO75777A (ro) Procedeu pentru prepararea unor 1,2-benzizotiazolin-3-one
NO770366L (no) Fremgangsm}te for fremstilling av meta-aryloksy-benzaldehyder.
SE436570B (sv) Forfarande for framstellning av n-(5-tetrazolyl)-4-oxo-4h-pyrimido/2,1-b/-bensotiazol-3-karboxamider med anti-allergisk verkan
DK314677A (da) Fremgangsmade il fremstilling af tic13.
SE7701459L (sv) Forfarande for framstellning av nya derivat av 1,2-ditiol
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
SE436751B (sv) Forfarande enligt krav 1 i patentet 7613920-3 (publ.nr 423903) for framstellning av 17alfa-acyloxi-9alfa, 21-dihalogen-11beta-hydroxi-6alfa-fluor-16beta-metyl-pregna-1,4-dien-3,20-dion-foreningar
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
NO149428C (no) Fremgangsmaate for fremstilling av fysiologisk aktive prostaglandinderivater.
RO81681A (ro) Procedeu pentru prepararea unor 1,2,3-tiadiazol-3-in-5-ilidenuree
NL7707086A (nl) Pyrazolo(1,5-c)chinazoline derivaten en werk- wijzen voor hun bereiding en toepassing.
IT1083440B (it) Procedimento per la fabbricazione di cerniere lampo
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
RO70629A (ro) Procedeu pentru prepararea 1,1-dioxidului de acid 3,4-dihidro-2-metil-4-oxo-2h-1,2-benzotiazin-3-carboxilic
SE423813B (sv) Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper
SE7707125L (sv) Forfarande for framstellning av 7-(alfa-(2,3, - dihydro-2-oxo-1h- bensimidazol -1- ylkarbomyl-amino) arylacetamido ) cefalasporiner
SE7700533L (sv) Forfarande for framstellning av 3,4-dihydro-2(1h)-kinazolinonderivat
HU174981B (hu) Sposob poluchenija n-skobka-1-allil-2-pirrolidilmetil-skobka zakryta-2,3-dimetoksi-5-sul'famoil-benzamida i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
DK131474B (da) Analogifremgangsmåde til fremstilling af 9alfa-halogen-11beta, 17alfa, 21-trihydroxy-16beta-metylpregna-1,4-dien-3,20-dion-21-adamantan-1'-karboxylater.
RO77922A (ro) Procedeu pentru prepararea unor indoldihidroindol-3-carboxamide dimere
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
SE7613411L (sv) Forfarande vid framstellning av n,n'-bis-tri-metylsilylkarbamid
AR215611A1 (es) Procedimiento de preparacion de derivados de alcoxicarbonil-2-tetrahidro tieno (3,2-c)piridina

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7706673-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7706673-6

Format of ref document f/p: F